UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A Systematic Review On Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection And Prevention Strategies

Sroczynski, G; Gogollari, A; Kuehne, F; Hallsson, LR; Widschwendter, M; Pashayan, N; Siebert, U; (2020) A Systematic Review On Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection And Prevention Strategies. Cancer Prevention Research , 13 (5) pp. 429-442. 10.1158/1940-6207.CAPR-19-0506. Green open access

[thumbnail of Pashayan_Sroczynski et al -Sysematic Rev CE Oca - Ca Prev Res.pdf]
Preview
Text
Pashayan_Sroczynski et al -Sysematic Rev CE Oca - Ca Prev Res.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Ovarian cancer imposes a substantial health and economic burden. We systematically reviewed current health-economic evidence for ovarian cancer early-detection or prevention strategies. Accordingly, we searched relevant databases for cost-effectiveness studies evaluating ovarian cancer early-detection or prevention strategies. Study characteristics and results including quality-adjusted life years (QALY), and incremental cost-effectiveness ratios (ICERs) were summarized in standardized evidence tables. Economic results were transformed into 2017 Euros. The included studies (N=33) evaluated ovarian cancer screening, risk-reducing interventions in women with heterogeneous cancer risks and genetic testing followed by risk-reducing interventions for mutation carriers. Multimodal screening with a risk-adjusted algorithm in postmenopausal women achieved ICERs of 9,800-81,400 Euros/QALY, depending on assumptions on mortality data extrapolation, costs, test performance and screening frequency. Cost-effectiveness of risk-reducing surgery in mutation carriers ranged from cost-saving to 59,000 Euros/QALY. Genetic testing plus risk-reducing interventions for mutation carriers ranged from cost-saving to 54,000 Euros/QALY in women at increased mutation risk. Our findings suggest that preventive surgery and genetic testing plus preventive surgery in women at high risk for ovarian cancer can be considered effective and cost-effective. In postmenopausal women from the general population, multimodal screening using a risk-adjusted algorithm may be cost-effective.

Type: Article
Title: A Systematic Review On Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection And Prevention Strategies
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1158/1940-6207.CAPR-19-0506
Publisher version: https://doi.org/10.1158/1940-6207.CAPR-19-0506
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Ovarian cancer, cost-effectiveness, prevention, decision analysis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Applied Health Research
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Womens Cancer
URI: https://discovery.ucl.ac.uk/id/eprint/10093548
Downloads since deposit
144Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item